153 results
6-K
EX-99.3
BLRX
Bioline Rx Ltd
28 May 24
BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate
7:11am
functions. Other significant costs include marketing and communication materials, market access activities, professional fees for outside market research
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents … or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
’ meetings and arrange to deliver our voting materials to them if we ask it to. Those materials will describe the matters to be voted on and explain … the Depositary if one of the conditions specified above exists.
We cannot assure you that you will receive the voting materials in time to ensure
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
business.
We deal with hazardous materials and must comply with environmental, health and safety laws and regulations, which can be expensive … of our information technology systems and related data.
We deal with hazardous materials and must comply with environmental, health and safety laws
F-3
nyzmnf j4e
29 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-99
y3br0 jou2w
20 Nov 23
BioLineRx Reports Third Quarter 2023 Financial Results and Recent Corporate
7:03am
6-K
EX-99
f4v4f21
30 Aug 23
BioLineRx Reports Second Quarter 2023 Financial Results and Recent Corporate
7:15am
6-K
EX-99
lzib adbuh8rk
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
ijax0 2pj
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
tqueuc1f0xui7lslth4p
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
6-K
EX-99
djd40i3yn kxl0jme2
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
6-K
EX-99
mnh2ve9d 9z
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am
6-K
EX-10.1
rebn3rgbqyacpakisb0
21 Sep 22
Current report (foreign)
8:00am
424B5
oytwee67
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
to0lms4q 7qfaye
15 Sep 22
Current report (foreign)
8:39am
6-K
EX-99
8ne2o ul9gov3j2
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
pgasv8wwvq7l5
11 May 22
BioLineRx Reports First Quarter 2022 Financial Results
7:14am